CLAIM CARD
Mechanistically, the observed cardiometabolic benefits across these interventions converge on shared pathways of inflammation reduction and metabolic improvement. The clinical RCT by Abassi 2026 directly links walking to reduced inflammation, while Zhou 2026's meta-analysis highlights the anti-inflammatory potential of a high-phenolic diet in a chronic kidney disease population. Preclinical data and the mechanistic human study framework of Yerrabelli 2026 suggest lifestyle intervention attenuates endoplasmic reticulum stress and inflammation, enhancing immune cell identity. These mechanistic substrates—modulation of inflammatory pathways like C-reactive protein and improvement of insulin sensitivity—are central to the hypothesized geroprotective action of interventions on cardiometabolic health.
Evidence grade: exploratory
Contradiction status: none
Publication: 4ff5f065-8b09-4580-9cbc-da14dbcaa1fa
Provenance: Derivation Web chain
Citation Support
source_1Flensted-Jensen 2025source_2Saeed 2026source_3Zhu 2026source_4Navarese 2026source_5Yan 2024